Treatment Outcome of Short Implant Assisted Mandibular Overdenture in Combination With Low Level Laser Therapy
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Atrophy of Edentulous Mandibular Alveolar Ridge
- Sponsor
- Sara Zayed
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Assessment of changes in implant stability (Implant Stability Quotient).
- Last Updated
- 4 years ago
Overview
Brief Summary
This study evaluates the use of short dental implants to support mandibular overdenture together with the use of laser therapy for treatment of patients with atrophic ridges. All participants will receive laser therapy; half of participants will receive two short implants and the other half will receive four short implants.
Detailed Description
The conventional solution to complete edentulism is the use of complete removable dentures. One negative effect of edentulism is resorption of the edentulous ridge over time. Construction of a successful mandibular complete denture for patients with advanced mandibular ridge resorption is often difficult and on some occasions virtually impossible. It has been proved that when implants are placed, bone gets stimulated resulting in minimal bone loss. But anatomic limitations to implant placement have been observed in atrophic ridges, so short implants introduced as a recent alternative to aggressive surgical procedures proposed to compensate for tissue deficiency. Also, Low Level Laser Therapy (LLLT) has proven success in improving implant stability which is very crucial in short implants. Thus, the purpose of this study is to evaluate and compare the treatment outcome of mandibular overdenture assisted by two short implants versus that assisted by four short implants in combination with LLLT.
Investigators
Sara Zayed
Director
Alexandria University
Eligibility Criteria
Inclusion Criteria
- •Completely edentulous patients.
- •Patients with mandibular resorbed edentulous ridge.
- •Medically fit patients with no systemic conditions.
- •Class I ridge relation.
- •Adequate zone of keratinized mucosa.
Exclusion Criteria
- •Metabolic bone disease or unstable systemic condition.
- •Heavy smokers.
- •A history of radiotherapy in the head and neck region.
- •Physical or mental disability.
- •Temporomandibular and neuromuscular disorders.
Outcomes
Primary Outcomes
Assessment of changes in implant stability (Implant Stability Quotient).
Time Frame: Baseline, 6 months &12 months.
Implant stability can be defined as the absence of clinical mobility. It will be assessed at the time of implant placement (baseline) ,then six months and twelve months later, by the resonance frequency analysis using Osstel devise which measure implant oscillation frequency on the bone;Implant Stability Quotient (ISQ) .
Secondary Outcomes
- Peri-implant marginal bone changes.(Baseline, 6 months &12 months.)
- Assessment of changes in peri-implant probing depth .(Baseline, 6 months &12 months.)
- Assessment of changes in modified gingival index(Baseline, 6 months &12 months.)